“A plea for individualized prostate cancer screening”

For some years, Vickers, Lilja, and their associates have been arguing that baseline PSA level is able to predict long-term risk for prostate cancer, and now a new paper in European Urology seems to provide support for this argument and a practical clinical strategy for its application. … READ MORE …

Shared and emotion-free decision-making with respect to PSA-based screening

The following is (slightly edited) report by Jeffrey J. Tomaszewski, MD, on behalf of UroToday.com, of a state-of-the-art lecture by David Penson, MD, presented at the annual meeting of the American Urological Association (AUA) in Orlando. We hope that UroToday will forgive us for this direct “theft”, but the topic is one of enormous relevance to the patient community. … READ MORE …

Liu and Zoey “are Ferraris” who massively outperform PSA testing

A report on the Medscape Oncology site on Tuesday discussed prostate cancer detection data presented at the annual meeting of the American Urological Association (AUA) by a group of Italian researchers — with the help of two highly trained German Shepherds. … READ MORE …

A 13-year update from the ERSPC screening trial

So one of the presentations given at the recent EAU meeting in Stockholm was an update, by Dr. Jonas Hugosson, at a median 13 years of follow-up, from the European Randomized Study of Screening for Prostate Cancer (ERSPC)  — and there is some good news, but maybe not enough to get carried away by … yet. READ MORE …

“Five golden rules” for prostate cancer screening and treatment today

In a very simple and straightforward article in European Urology, Vickers et al. have clearly laid out a series of five “golden rules” that, in their opinion, all physicians should be following today when they are testing men for risk of prostate cancer through the use of the PSA test. … READ MORE …

More data that will cause controversy in the screening debate

Data from a very large, 25-year-long, randomized, controlled trial of screening for cancer has cast further doubt on the value of mass, annual, population-based screening as a way to reduce cancer deaths. … READ MORE …

UroToday interviews with D’Amico, Klotz, Mulhall

Many readers of this blog may be interested in listening to one or more of a series of recent, relatively short audio-interviews with respected opinion-leaders in the prostate cancer diagnosis and management community, conducted by the medical director of UroToday. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,142 other followers